Ventria Bioscience Inc. v. International Trade Commission

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
VENTRIA BIOSCIENCE INC.,
Appellant
v.
INTERNATIONAL TRADE COMMISSION,
Appellee
WUHAN HEALTHGEN BIOTECHNOLOGY
CORPORATION,
Intervenor
______________________
2023-1172
______________________
Appeal from the United States International Trade
Commission in Investigation No. 337-TA-1238.
-------------------------------------------------
WUHAN HEALTHGEN BIOTECHNOLOGY CORP.,
Appellant
v.
INTERNATIONAL TRADE COMMISSION,
Appellee
VENTRIA BIOSCIENCE INC.,
Intervenor
Case: 23-1172 Document: 21 Page: 1 Filed: 03/14/2023

-- 1 of 3 --

WUHAN HEALTHGEN BIOTECHNOLOGY CORP . v. ITC 2
______________________
2023-1389
______________________
Appeal from the United States International Trade
Commission in Investigation No. 337-TA-1238
______________________
ON MOTION
______________________
O R D E R
Ventria Bioscience Inc. moves unopposed to voluntarily
dismiss Appeal No. 2023-1172 pursuant to Federal Rule of
Appellate Procedure 42(b) and the parties’ agreement as to
the allocation of costs.
Upon consideration thereof,
I T I S O RDERED T HAT :
(1) The motion is granted. Appeal No. 2023-1172 is
dismissed.
(2) Each party shall bear its own costs for Appeal No.
2023-1172.
(3) The revised official caption for Appeal No. 2023-
1389 is reflected in this order.
(4) Wuhan Healthgen Biotechnology Corp.’s opening
brief in Appeal No. 2023-1389 is due no later than 60 days
Case: 23-1172 Document: 21 Page: 2 Filed: 03/14/2023

-- 2 of 3 --

WUHAN HEALTHGEN BIOTECHNOLOGY CORP . v. ITC 3
from the date of filing of this order.
March 14, 2023
Date
F OR THE COURT
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court
ISSUED AS A MANDATE (for 2023-1172 only):
March 14, 2023
Case: 23-1172 Document: 21 Page: 3 Filed: 03/14/2023

-- 3 of 3 --